BioCentury | Apr 4, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: March 2019

...ZDHHC13 or inhibiting LYPLA2 could help treat melanoma University of Oxford ; Shandong University ; Boston University School of Medicine...
BioCentury | Mar 5, 2019
Distillery Therapeutics

MC1R, ZDHHC13 and LYPLA2 as new targets for melanoma

...Zhou, Shandong University, Shandong, China email: junzhou@sdnu.edu.cn CONTACT: Rutao Cui, Boston University School of Medicine, Boston, Mass. email: rutaocui@bu.edu Claire Quang Boston University School of Medicine Shandong...
BioCentury | Feb 11, 2019
Distillery Therapeutics

Cancer

...Deng, Xiamen University, Fujian, China email: xmdeng@xmu.edu.cn CONTACT: Rutao Cui, Boston University School of Medicine, Boston, Mass. email: rutaocui@bu.edu Claire Quang Boston University School of Medicine Fudan...
BioCentury | Jun 28, 2018
Emerging Company Profile

Stress relief for neurons

...the stress response,” said Wolozin, who is also a professor of pharmacology and neurology at Boston University School of Medicine...
...TDP-43 aggregates Companies and Institutions Mentioned Aquinnah Pharmaceuticals, Cambridge, Mass. Biogen Inc. (NASDAQ:BIIB), Cambridge, Mass. Boston University School of Medicine...
...DNA binding protein 43 TIA1 - TIA1 cytotoxic granule associated RNA-binding protein Alicia Parker, Staff Writer Aquinnah Pharmaceuticals Boston University School of Medicine Alzheimer's...
BioCentury | Feb 2, 2018
Company News

Eisai, Boston University School of Medicine partner to study microglia in AD

...Eisai Co. Ltd. (Tokyo:4523) and the Boston University School of Medicine partnered to study the effects of Alzheimer’s disease-associated genetic...
...provide financial terms. Eisai Co. Ltd. (Tokyo:4523), Tokyo, Japan Boston University School of Medicine, Boston, Mass. Business: Neurology Jaime De Leon Boston University School of Medicine Eisai...
BioCentury | Jan 4, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: December 2017

...inhibitor of GBA motif proteins, including CCDC88C, NUCB1 and NUCB2, could help treat breast cancer. Boston University School of Medicine...
BioCentury | Dec 14, 2017
Translation in Brief

STUBbing out thrombosis

...Last month in a paper published in Science Translational Medicine , a group led by Boston University School of Medicine...
...axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk.” Science Translational Medicine (2017) Lauren Martz, Senior Writer Boston University School of Medicine STIP1...
BioCentury | Dec 13, 2017
Distillery Therapeutics

Endocrine / Metabolic

...Ronzitti, Genethon, Evry, France email: gronzitti@genethon.fr CONTACT: Federico Mingozzi, same affiliation as above email: fmingozzi@genethon.fr Hongjiang Li Boston University School of Medicine Genethon Acid...
BioCentury | Dec 5, 2017
Distillery Techniques

Chemistry

...published online Nov. 13, 2017 doi:10.1073/pnas.1707992114 CONTACT: Mikel Garcia-Marcos, Boston University School of Medicine, Boston, Mass. email: mgm1@bu.edu Hongjiang Li Boston University School of Medicine Coiled-coil...
BioCentury | Apr 20, 2017
Finance

Zuckerberg’s research network

...program to develop biomarkers for the vascular contributions to cognitive impairment and dementia. Researchers from Boston University School of Medicine...
Items per page:
1 - 10 of 85
BioCentury | Apr 4, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: March 2019

...ZDHHC13 or inhibiting LYPLA2 could help treat melanoma University of Oxford ; Shandong University ; Boston University School of Medicine...
BioCentury | Mar 5, 2019
Distillery Therapeutics

MC1R, ZDHHC13 and LYPLA2 as new targets for melanoma

...Zhou, Shandong University, Shandong, China email: junzhou@sdnu.edu.cn CONTACT: Rutao Cui, Boston University School of Medicine, Boston, Mass. email: rutaocui@bu.edu Claire Quang Boston University School of Medicine Shandong...
BioCentury | Feb 11, 2019
Distillery Therapeutics

Cancer

...Deng, Xiamen University, Fujian, China email: xmdeng@xmu.edu.cn CONTACT: Rutao Cui, Boston University School of Medicine, Boston, Mass. email: rutaocui@bu.edu Claire Quang Boston University School of Medicine Fudan...
BioCentury | Jun 28, 2018
Emerging Company Profile

Stress relief for neurons

...the stress response,” said Wolozin, who is also a professor of pharmacology and neurology at Boston University School of Medicine...
...TDP-43 aggregates Companies and Institutions Mentioned Aquinnah Pharmaceuticals, Cambridge, Mass. Biogen Inc. (NASDAQ:BIIB), Cambridge, Mass. Boston University School of Medicine...
...DNA binding protein 43 TIA1 - TIA1 cytotoxic granule associated RNA-binding protein Alicia Parker, Staff Writer Aquinnah Pharmaceuticals Boston University School of Medicine Alzheimer's...
BioCentury | Feb 2, 2018
Company News

Eisai, Boston University School of Medicine partner to study microglia in AD

...Eisai Co. Ltd. (Tokyo:4523) and the Boston University School of Medicine partnered to study the effects of Alzheimer’s disease-associated genetic...
...provide financial terms. Eisai Co. Ltd. (Tokyo:4523), Tokyo, Japan Boston University School of Medicine, Boston, Mass. Business: Neurology Jaime De Leon Boston University School of Medicine Eisai...
BioCentury | Jan 4, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: December 2017

...inhibitor of GBA motif proteins, including CCDC88C, NUCB1 and NUCB2, could help treat breast cancer. Boston University School of Medicine...
BioCentury | Dec 14, 2017
Translation in Brief

STUBbing out thrombosis

...Last month in a paper published in Science Translational Medicine , a group led by Boston University School of Medicine...
...axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk.” Science Translational Medicine (2017) Lauren Martz, Senior Writer Boston University School of Medicine STIP1...
BioCentury | Dec 13, 2017
Distillery Therapeutics

Endocrine / Metabolic

...Ronzitti, Genethon, Evry, France email: gronzitti@genethon.fr CONTACT: Federico Mingozzi, same affiliation as above email: fmingozzi@genethon.fr Hongjiang Li Boston University School of Medicine Genethon Acid...
BioCentury | Dec 5, 2017
Distillery Techniques

Chemistry

...published online Nov. 13, 2017 doi:10.1073/pnas.1707992114 CONTACT: Mikel Garcia-Marcos, Boston University School of Medicine, Boston, Mass. email: mgm1@bu.edu Hongjiang Li Boston University School of Medicine Coiled-coil...
BioCentury | Apr 20, 2017
Finance

Zuckerberg’s research network

...program to develop biomarkers for the vascular contributions to cognitive impairment and dementia. Researchers from Boston University School of Medicine...
Items per page:
1 - 10 of 85